AstraZeneca plc vs Church & Dwight Co., Inc. — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Church & Dwight Co., Inc. trades at $103.35 (market cap $24.38B). The key difference: AstraZeneca plc is far larger — about 10.2× Church & Dwight Co., Inc.'s market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | CHD | |
|---|---|---|
Market Cap | $248.14B | $24.38B |
Sector | Health | Consumer Staples |
52-Week High | $209.48 | $105.26 |
52-Week Low | $147.06 | $81.60 |
Enterprise Value | $275.41B | $26.38B |
Dividend Yield | 2.01% | 1.2% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Church & Dwight is the leading producer of baking soda in the world. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Xtra, Trojan, OxiClean, First Response, Nair, L'il Critters/Vitafusion, Orajel, and WaterPik, which together with Arm & Hammer constitute more than 80% of its annual sales and profits. In early 2019, the firm announced the addition of Flawless, which manufactures electric shaving products for women. At the end of 2020, the firm acquired Zicam, a leading brand in the cough/cold-shortening category. Church & Dwight derives more than 80% of its sales from its home market in the U.S.
Read more on CHD →